Seventeen studies with over 1,000 participants were included in the review. Five studies were randomised controlled trials (RCTs; n=174) of a parallel or crossover design using, generally, multiple daily injections as a comparator
The studies reported mixed results. Focusing solely on the RCTs, one reported quality-of-life benefits, three reported mixed results, and one reported no evidence of quality-of-life benefits.